SLC11A2 / Natural resistance-associated macrophage protein 2 · Western blot design guide

Design a Western Blot for SLC11A2

Source-linked SLC11A2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SLC11A2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for SLC11A2: expected band ~62.3 kDa, hero antibody A02622-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable SLC11A2 Western blot protocol sheet — expected band ~62.3 kDa, antibody A02622-2, controls and PMC citations. Open the full SLC11A2 WB guide →

SLC11A2 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~62.3 kDa
Observed band Approximately 70 kDa
Gel 10% (catalog A02622-2)
Positive control ⓘ Salivary gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Phosphorylated
Caveat Modification-state controls
Gene-set association MSigDB Hallmark membership
Isoform 5 isoform(s)
Section 1

Source-Linked SLC11A2 Western Blot Protocol Options

The A02622-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Caco-2, human 293T, rat RH-35 (catalog A02622-2)
Gel %10% (catalog A02622-2)
Load30 ug; reducing conditions (catalog A02622-2)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02622-2)
Membranenitrocellulose membrane (catalog A02622-2)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A02622-2)
Primary antibodyA02622-2 · 1:1000 (catalog A02622-2)
Primary incubationovernight at 4°C (catalog A02622-2)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A02622-2)
Secondary incubation1.5 hour at RT (catalog A02622-2)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A02622-2)
DetectionECL (catalog A02622-2)
Section 2

What Is the Expected SLC11A2 Western Blot Band Size?

SLC11A2 is predicted at 62.3 kDa and observed near 70 kDa; the cause of the difference is not established.

What am I looking at on my blot?
Band near 70 kDaEmpirical SLC11A2 band in reducing whole-cell lysates; confirm identity with controls
Band near 62 kDaNear the 62.3 kDa predicted sequence mass; confirm identity with controls
Several discrete bandsFive splice isoforms exist, but distinct migration has not been established
Diffuse band or smearHeterogeneity at the two N-linked glycosylation sites is possible but unverified
💡Expected SLC11A2 appearanceSLC11A2 has a predicted mass of 62.3 kDa and an empirical band near 70 kDa in reducing whole-cell lysates; the cause of the difference is unestablished, so use ordinary band-identity controls.
How each factor affects band size
Predicted sequence mass62.3 kDa before any apparent migration effects
N-linked glycosylation at Asn336May increase apparent mass; the size effect is unestablished
N-linked glycosylation at Asn349May increase apparent mass; the size effect is unestablished
Splice isoforms 1, 2, 3, 4 and 5May differ in size; distinct band positions are unestablished
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateMembrane-localized SLC11A2 may be poorly recoveredCheck membrane protein extraction and a positive-control lysate
Band higher than expectedN-linked glycosylation may affect migration, but the cause of the 70 kDa band is unestablishedConfirm band identity and compare migration after deglycosylation
Band lower than expectedAn alternative splice product is possible, but its migration is unknownCheck antibody epitope coverage and confirm band identity
Broad smear instead of sharp bandHeterogeneous glycosylation is possible but unverifiedCompare treated and untreated samples after deglycosylation
Multiple bandsFive splice isoforms exist, but separate bands are unverifiedCheck isoform expression and antibody specificity
Weak or no signalMembrane-localized protein may be underrepresented in the sampleAssess membrane protein recovery and include a positive-control lysate

Sample controls for SLC11A2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for SLC11A2 in Western blot, you can use salivary gland tissue, where HPA reports high expression.
Positive control: Salivary gland (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: As a multi-pass membrane protein, SLC11A2 may require effective membrane protein extraction for a clear signal.

HPA tissue expression evidence for SLC11A2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Salivary gland glandular cells High Protein (IHC) HPA →
Adrenal gland glandular cells Medium Protein (IHC) HPA →
Breast glandular cells Medium Protein (IHC) HPA →
Bronchus respiratory epithelial cells Medium Protein (IHC) HPA →
Caudate neuronal cells Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Cerebellum cells in granular layer Not detected Protein (IHC) HPA →
Hippocampus glial cells Not detected Protein (IHC) HPA →
Lymph node germinal center cells Not detected Protein (IHC) HPA →
Oral mucosa squamous epithelial cells Not detected Protein (IHC) HPA →
Section 3

Advanced SLC11A2 Western Blot Tips

Deeper troubleshooting and optimisation questions for SLC11A2, answered from its protein features.

How should SLC11A2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Which SLC11A2 isoforms could affect band interpretation?
Isoforms · UniProt lists isoforms 1–5. Isoform 5 changes the N-terminal residues 1–12; isoforms 3 and 4 have an alternative N terminus; and isoforms 1, 3, and 5 replace residues 544–568. Check which sequence your antibody recognizes before assigning bands to isoforms. These sequence differences do not establish that the isoforms resolve as separate bands.
Which listed modifications matter when interpreting SLC11A2 bands?
PTM · UniProt lists N-linked glycosylation at Asn336 and Asn349 and phosphoserine at Ser564 and Ser567, using the supplied canonical sequence coordinates. Isoforms 1, 3, and 5 replace the segment containing Ser564 and Ser567. Check isoform identity before interpreting a phosphorylation-sensitive result; the listed sites alone do not establish a visible band shift.
Does this guide establish induction of SLC11A2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for SLC11A2 Western blot?
Transfer · SLC11A2 is annotated as a multipass membrane protein, but the supplied features do not specify a transfer method. Optimize transfer for the approximately 70 kDa apparent band and check both the membrane and post-transfer gel for retained protein before interpreting a weak signal.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02622-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
What should be controlled when quantifying SLC11A2 bands?
Quantitation · Compare samples using the same band assignment and account for isoform coverage by the antibody. Record iron or cobalt exposure because the supplied record links these treatments to SLC11A2 degradation in cortical neurons. Quantify a consistently identified band rather than combining unresolved bands that may represent different forms.
Why might SLC11A2 appear near 70 kDa instead of 62.3 kDa?
Interpretation · The supplied apparent band is approximately 70 kDa, versus a predicted mass of 62.3 kDa. UniProt lists N-linked glycosylation at Asn336 and Asn349 and five isoforms, but these features alone do not establish the cause of the difference. Compare the band with a molecular weight marker and assess glycosylation and isoform identity when interpreting it.

In cortical neurons, the supplied UniProt record says iron or cobalt exposure promotes interaction with NDFIP1 and NEDD4L, followed by NEDD4L-mediated ubiquitination and proteasome-dependent degradation. Record exposure and sampling time when comparing band intensity; a weaker signal under these conditions could reflect reduced SLC11A2 abundance.

First compare them with the approximately 70 kDa observed band and the 62.3 kDa predicted mass. Then check antibody recognition across the five isoforms, including their alternative termini, and consider the listed glycosylation sites at Asn336 and Asn349. The supplied features suggest possibilities for follow-up, but do not identify any particular unexpected band.
Boster reagents

SLC11A2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of DMT1/SLC11A2 using anti-DMT1/SLC11A2 antibody (A02622-2). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Caco-2 whole cell lysates, Lane 2: human 293T whole cell lysates, Lane 3: rat RH-35 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-DMT1/SLC11A2 antigen affinity purified polyclonal antibody (A02622-2) at 1:1000 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for DMT1/SLC11A2 at approximately 70 kDa. The expected band size for DMT1/SLC11A2 is at 62 kDa.
Anti-DMT1/SLC11A2 Antibody
Cat # A02622-2
Real WB data Western blot analysis of extracts of various cell lines, using DMT1/SLC11A2 Rabbit pAb at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 180s.
Anti-SLC11A2 Antibody
Cat # A02622

A02622-2 and A02622 both list human, mouse, and rat reactivity and have WB images. A02622-2 documents human Caco-2 and 293T and rat RH-35 lysates, with a band near 70 kDa versus 62 kDa expected. A02622’s caption does not identify its cell lines.

Which to pick: Choose A02622-2 for documented human or rat lysate examples. A02622 also has a WB image, but its caption does not identify the cell lines. Neither image documents a mouse sample.

Source: BosterBio SLC11A2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.